Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc.

Statement of Changes in Beneficial Ownership

Initial Statement of Beneficial Ownership

Insider	Title	Date	Shares	% Owned	Market Value
Marc N. Casper	Chairman, President & CEO, Independent Director Show All	2024-09-04	175.58K	0.04596%	$107.44M
Scott M. Sperling	President and Director, Co-Chief Executive Officer, Co-President, Director, Chairman, Independent Lead Director, Manager, Independent Director Show All	2024-05-22	72.07K	0.01887%	$44.1M
Stephen Williamson	Senior VP & CFO Show All	2024-08-28	39.97K	0.01046%	$24.46M
Michel Lagarde	Executive VP & COO, Independent Director, Director Show All	2024-08-28	16.98K	0.00445%	$10.39M
Gianluca Pettiti	Executive Vice President Show All	2024-08-28	16.96K	0.00444%	$10.38M
Michael D. Shafer
Jim P. Manzi
Nelson Juseuk Chai
Lisa P. Britt
Michael A. Boxer
Frederick M. Lowery
Lars Rebien Sorensen
C. Martin Harris
Tyler E. Jacks
Dion J. Weisler